After around 8 weeks in lockdown and 3 months since the spectre of Covid-19 loomed large in our media headlines, why is it that a team of frontline critical (intensive) care doctors in the USA who have delivered close to 100% survival with their unique protocol being roundly ignored? Wouldn’t you think that hospitals and governments would be biting their hands off to get a hold of their protocol? Or clamouring for more information and training to understand why their own outcomes from standard care fall so far short, delivering around just 50% survival in most critical care settings?

We certainly would, which is why we’ve dug a little deeper into the available critical care data for this article.

  • Find related articles, information and videos in our Covid Zone

It’s now very clear that the outcomes among the very seriously ill patients in critical care units (also referred to as ICU [intensive care units]/ITU [intensive therapy units] in the UK) are being used to inform lockdown (or lock up!) strategy and keep the fear levels sufficiently high to ensure citizen compliance.

Is there flex in critical care protocols?

Limited published data would suggest that critical medical care in many parts of the world is not flexing sufficiently to encompass treatment options to deliver the best possible outcomes, especially where these involve novel protocols and especially natural therapeutic agents. But why not? After all, this is the digital age where physical distance or time zone differences no longer present barriers to communication. The media is certainly sharing horror stories globally, many of which centre around the dire outcomes of the critically ill filling up the ICUs.

It’s impossible to over-estimate how important outcomes in these critical care settings are. High levels of success would significantly reduce the pain and suffering for the diseased, their families and their loved ones. It would also change greatly our perception of the threat posed by the disease.

To expedite research around this new infection, the obstacle course posed by the peer review process to scientific publication has been removed. Yet, despite many front line doctors using different protocols to the standard, conventional care, to great success (aka. better survival) their data are not being received where it counts. We all need to be asking why. After all, people are dying. How would it make relatives feel if it was found that their loved one had died needlessly just because the doctors who were having greatest success were not being listened to and their innovative protocols had been systematically ignored?

Survival outcomes that shouldn't be ignored

Dr Pierre Kory, and his colleagues in the Front Line Critical Care Working Group (FLCCC) are certainly demonstrating outcomes that shouldn’t be ignored, but are.

Dr Kory stated in the US Homeland Security Committee Round Table on Covid-19 last week, that their protocol has gone to the White House on 4 occasions, they have a website, have been widely interviewed for videos as well as print, yet no one in authority has tried to make contact. Worse, he states that they are being pushed back continually by the US Centers for Disease Control (CDC) and the National Institute for Health (NIH).

It’s no wonder he sounds so impassioned. Can you imagine how difficult it is for a team of experienced critical care doctors to see outcomes change dramatically from the normal standard of care to 98% survival with their MATH+ protocol, yet no one seems interested? Having now treated 100 critically ill patients, they report that they have only lost two people, both who were over 80 years of age with advanced chronic conditions. The rest were discharged in good general health after short hospital stays and none were ventilator dependent.

Surely that’s news that every hospital would be all over and we’d be seeing changes to the standard of care? Yet nothing of the kind appears to be happening. Instead Kory and his seven colleagues are being effectively stonewalled whilst more people die.

What do the data say?

The first thing to say is that data comparisons are in any event very difficult owing to different resources available, different patient characteristics and vulnerabilities, ages and ethnicities etc. Additionally, only around 12 studies from critical care facilities are published and only 3 of these, one from China, one from the ICUs of the Lombardy region of Italy and the comprehensive data from ICNARC in the UK involve over 1000 patients. Of these large studies, the Chinese and UK data suggests survival rates of almost exactly 50% and the Lombardy study stands out with its significantly higher survival at 75%. 

Four studies from the US are all small and one involves the report of the total number of cases treated by a team of clinical care doctors working in different facilities, but using the FLCCC Working Group MATH+ protocol, which as we've described above, has only disclosed 2 deaths in 100 patients. This is the real stand out figure. Another US study from Boston showed 83% survival and an earlier study from Washington State showed the lowest survival rate of just 33%, but over 70% of these were mechanically ventilated and the study was small.

  • We're funded only by donations. Any amount is welcomed to help us continue our work

Another feature of these data is the lack of consistency in reporting techniques which significantly lowers the ability for different critical care doctors to learn rapidly from each other, despite the inevitable variation in resources and patient profiles. And of course, the other real stand out, as mentioned, are the results from the FLCCC Working Group. The numbers may be small, but they nevertheless exceed considerably two of the US studies (one published in JAMA, the other in NEJM) and it could be considered a form of medical negligence that health authorities such as the NIH and CDC in the US have ignored their persistent efforts to communicate their findings and protocols.

Table 1. Summary data from key studies or reports from critical care facilities treating Covid-19 patients.

Study location

No of patients

% mortality

% Male/
Female

Treatments

Single hospital in Wuhan, China

52

62

67/33

High flow nasal cannula | mechnical ventilation | prone position | Extracorporeal membran oxygenation | renal replacement therapy | vasoconstrivtie agents | antiviral agents | antibacterial agents | glucocorticoids

Link to source

Chinese CDC data

2087

49

ND

ND

Link to source

Sichuan province data, China

81

12

63/37

Respiratory support | Parenteral nutrition | Prone position | blood transfsion | Lopinavir or Ritonavir | Abidol | Ribavirin | nebulised recombinant human interfereon a2b | Thymosin a | Immunoglobuling | methylprnisolone | antibiotics | analgesics or sedatives

Link to source

Washington State only, USA

21

67

52/48

Ventiilation used for 15 px, all had ARDS.  8 developed severe ARDS in 72 hrs. 27% have remained critically ill. 9.5% discharged.

Link to source

9 Seattle-based hospitals, USA

24

50

63/37

75% needed ventilation, 17 also had hypotension and needed vasopressors. 50% died between day 1 -18. 12 survived - 5 went home, 4 went to other wards and 3 stayed on ventilation. Most common reason for admittance to ICU was hypoxaemic respiratory failure.

Link to source

USA

100

2

ND

Corticosteroids (methylprednisolone, vitamin C & blood thinners (heparin)

Link to source

Boston, USA

66

17

65/35

ND

Link to source

Country wide, Canada

868

 

65/35

ICU: 106 aged 80+; 458 60-79; 273 40-59; 53 20-39

Link to source

England, Wales, NI

5139

49

71/29

ND

Link to source

England, Wales, NI

6143

47

71/29

ND

Link to source

ICUs of Lombardy Region, Italy

1591

25

82/18

ND

Link to source

Swedish ICUs country wide

1784

ND

74/26

ND

Link to source

 ND – no data

Falling on deaf ears

Why won’t health authorities and governments listen to expert front line critical care doctors who are getting well above average results?

Why are all of the ongoing and repeated attempts by many groups, organisations (ours included), doctors, health professionals and citizens to get health authorities and governments to look at the evidence behind novel and natural protocols for immune support and treatment consistently falling on deaf ears?

And, why is there such widespread censorship of anything but the party line by online platforms which lack sufficient expertise to adjudicate on matters of science and medicine?

The public-facing narrative continues to profess that there is nothing you can do to support your immune system, there is nothing in the natural arsenal for Covid-19 (apart from a gnat’s dose of vitamin D perhaps), social distancing must be maintained at all times and that the only cure for this terrifying infection will magically come from a vaccine created at warp speed.

When you add these untruths to the plans being rolled out for ramping up citizen surveillance through test, track and trace, the erosion of our rights and freedoms through the emergency coronavirus legislation, the destruction of economies and the forced reliance of so many on the state for survival handouts, you realise how much we might lose whilst much of the world cowers behind closed doors in fear.

We are paying the piper with our lives and our livelihoods. For more on ‘the piper’ or pipers... see our latest video from Rob Verkerk PhD.

 

Visit our Covid Zone

Return to the homepage